Benjamin Hackel,Arutselvan Natarajan,Sanjiv S. Gambhir
申请号：
US14204039
公开号：
US20140271467A1
申请日:
2014.03.11
申请国别(地区):
US
年份:
2014
代理人:
摘要：
Embodiments of the present disclosure provide for labeled probes such as a 64Cu-FN3 probe (FN3 refers to fibronectin type 3 domain) methods of making labeled probes pharmaceutical compositions including labeled probes methods of using labeled probes methods of diagnosing, localizing, monitoring, and/or assessing non-Hodgkins lymphoma, cancers, tumors, precancerous cells, and related biological events using labeled probes kits for diagnosing, localizing, monitoring, and/or assessing non-Hodgkins lymphoma, cancers, tumors, precancerous cells, and related biological events and the like.
